| pubmed-article:17219135 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17219135 | lifeskim:mentions | umls-concept:C2936350 | lld:lifeskim |
| pubmed-article:17219135 | lifeskim:mentions | umls-concept:C0078056 | lld:lifeskim |
| pubmed-article:17219135 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:17219135 | lifeskim:mentions | umls-concept:C1537028 | lld:lifeskim |
| pubmed-article:17219135 | lifeskim:mentions | umls-concept:C1517004 | lld:lifeskim |
| pubmed-article:17219135 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:17219135 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:17219135 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:17219135 | pubmed:dateCreated | 2007-5-17 | lld:pubmed |
| pubmed-article:17219135 | pubmed:abstractText | VCAM-1 plays a major role in the chronic inflammatory processes present in vulnerable atherosclerotic plaques. The residues 75-84 (B2702-p) and 84-75/75-84 (B2702-rp) of the major histocompatibility complex-1 (MHC-1) molecule B2702 were previously shown to bind specifically to VCAM-1. We hypothesised that radiolabelled B2702-p and B2702-rp might have potential for the molecular imaging of vascular cell adhesion molecule-1 (VCAM-1) expression in atherosclerotic plaques. | lld:pubmed |
| pubmed-article:17219135 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17219135 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17219135 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17219135 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17219135 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17219135 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17219135 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17219135 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17219135 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17219135 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17219135 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17219135 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:17219135 | pubmed:issn | 1619-7070 | lld:pubmed |
| pubmed-article:17219135 | pubmed:author | pubmed-author:FagretDD | lld:pubmed |
| pubmed-article:17219135 | pubmed:author | pubmed-author:DumaHH | lld:pubmed |
| pubmed-article:17219135 | pubmed:author | pubmed-author:GhezziCC | lld:pubmed |
| pubmed-article:17219135 | pubmed:author | pubmed-author:RiosL SLS | lld:pubmed |
| pubmed-article:17219135 | pubmed:author | pubmed-author:BoturynDD | lld:pubmed |
| pubmed-article:17219135 | pubmed:author | pubmed-author:BroisatAA | lld:pubmed |
| pubmed-article:17219135 | pubmed:author | pubmed-author:ArdissonVV | lld:pubmed |
| pubmed-article:17219135 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17219135 | pubmed:volume | 34 | lld:pubmed |
| pubmed-article:17219135 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17219135 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17219135 | pubmed:pagination | 830-40 | lld:pubmed |
| pubmed-article:17219135 | pubmed:meshHeading | pubmed-meshheading:17219135... | lld:pubmed |
| pubmed-article:17219135 | pubmed:meshHeading | pubmed-meshheading:17219135... | lld:pubmed |
| pubmed-article:17219135 | pubmed:meshHeading | pubmed-meshheading:17219135... | lld:pubmed |
| pubmed-article:17219135 | pubmed:meshHeading | pubmed-meshheading:17219135... | lld:pubmed |
| pubmed-article:17219135 | pubmed:meshHeading | pubmed-meshheading:17219135... | lld:pubmed |
| pubmed-article:17219135 | pubmed:meshHeading | pubmed-meshheading:17219135... | lld:pubmed |
| pubmed-article:17219135 | pubmed:meshHeading | pubmed-meshheading:17219135... | lld:pubmed |
| pubmed-article:17219135 | pubmed:meshHeading | pubmed-meshheading:17219135... | lld:pubmed |
| pubmed-article:17219135 | pubmed:meshHeading | pubmed-meshheading:17219135... | lld:pubmed |
| pubmed-article:17219135 | pubmed:meshHeading | pubmed-meshheading:17219135... | lld:pubmed |
| pubmed-article:17219135 | pubmed:meshHeading | pubmed-meshheading:17219135... | lld:pubmed |
| pubmed-article:17219135 | pubmed:meshHeading | pubmed-meshheading:17219135... | lld:pubmed |
| pubmed-article:17219135 | pubmed:meshHeading | pubmed-meshheading:17219135... | lld:pubmed |
| pubmed-article:17219135 | pubmed:meshHeading | pubmed-meshheading:17219135... | lld:pubmed |
| pubmed-article:17219135 | pubmed:meshHeading | pubmed-meshheading:17219135... | lld:pubmed |
| pubmed-article:17219135 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17219135 | pubmed:articleTitle | Molecular imaging of vascular cell adhesion molecule-1 expression in experimental atherosclerotic plaques with radiolabelled B2702-p. | lld:pubmed |
| pubmed-article:17219135 | pubmed:affiliation | INSERM, U340, Radiopharmaceutiques Biocliniques, 38700, La Tronche, France. | lld:pubmed |
| pubmed-article:17219135 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17219135 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17219135 | lld:pubmed |
